A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports

Title
A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports
Authors
Keywords
Progressive Multifocal Leukoencephalopathy, Reporting Odds Ratio, Label Change, Drug Pair, National Drug File Reference Terminology
Journal
DRUG SAFETY
Volume 39, Issue 6, Pages 561-575
Publisher
Springer Nature
Online
2016-03-05
DOI
10.1007/s40264-016-0409-x

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started